Prediction of MHC-peptide binding: a systematic and comprehensive overview

EM Lafuente, PA Reche - Current pharmaceutical design, 2009 - ingentaconnect.com
T cell immune responses are driven by the recognition of peptide antigens (T cell epitopes)
that are bound to major histocompatibility complex (MHC) molecules. T cell epitope …

MHCII-peptide presentation: an assessment of the state-of-the-art prediction methods

Y Yang, Z Wei, G Cia, X Song, F Pucci… - Frontiers in …, 2024 - frontiersin.org
Major histocompatibility complex Class II (MHCII) proteins initiate and regulate immune
responses by presentation of antigenic peptides to CD4+ T-cells and self-restriction. The …

Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine

M Oprea, F Antohe - Biologicals, 2013 - Elsevier
Staphylococcus aureus is an opportunistic pathogen causing various inflammatory diseases
from skin and tissue local infections, to serious life threatening infections including …

Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease

E Zonneveld-Huijssoon, S Albani… - Clinical & …, 2013 - academic.oup.com
Mucosal administration of an antigen eliciting bystander suppression at the site of
inflammation results in effective antigen-specific immunotherapy for autoimmune diseases …

Consensus classification of human leukocyte antigen class II proteins

I Saha, G Mazzocco, D Plewczynski - Immunogenetics, 2013 - Springer
Class II human leukocyte antigens (HLA II) are proteins involved in the human
immunological adaptive response by binding and exposing some pre-processed, non-self …

A simple pan-specific RNN model for predicting HLA-II binding peptides

Y Heng, Z Kuang, W Xie, H Lan, S Huang, L Chen… - Molecular …, 2021 - Elsevier
The prediction of human leukocyte antigen (HLA) class II binding peptides plays important
roles in understanding the mechanism of immune recognition and developing effective …

Modern Developments in Short Peptide Viral Vaccine Design

C Nilofer, M Arumugam, P Kangueane - Global Virology III: Virology in the …, 2019 - Springer
Vaccine design and development against viral diseases is multifaceted. Classical vaccines
(live-attenuated vaccines, inactivated vaccines, subunit, recombinant, polysaccharide …

Short peptide vaccine design and development: Promises and challenges

P Kangueane, G Sowmya, S Anupriya… - Global Virology I …, 2015 - Springer
Vaccine development for viral diseases is a challenge where subunit vaccines are often
ineffective. Therefore, the need for alternative solutions is crucial. Thus, short peptide …

[PDF][PDF] Structure modeling based computer aided T-cell epitope design.

G Sowmya, A Vaishnavi… - Bio Algorithms Med Syst., 2008 - bit.wl.cm.uj.edu.pl
Progress in computational modeling for structural biology has motivated the use of
molecular mechanics calculations for synthetic peptide design as potential T-cell epitopes …

[HTML][HTML] From Anna University to America and to Agriculture

P Kangueane - Bioinformation, 2021 - ncbi.nlm.nih.gov
Anna University (AU) is an awesome alma mater for attracting the attention of the invincible
through awareness from education. It is a place with a plan for preparing a palace in a …